Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Olaparib expiry date?

See the DrugPatentWatch profile for Olaparib

When does olaparib (Lynparza) patent or exclusivity expire?

I don’t have enough provided information to state a specific “olaparib expiry date” (for example, the exact day a patent or market exclusivity ends). “Expiry date” can mean different legal timelines depending on the country and which product/strength/formulation you mean (tablet vs. capsule, branded vs. generic, and whether the question is about patent expiry, data exclusivity, or marketing authorization exclusivity).

If you tell me the country (US, EU/UK, etc.) and the exact olaparib product (brand name and dosage form), I can narrow it to the relevant expiry timeline.

What do people usually mean by “expiry” for olaparib?

Searchers often want one of these, which can differ by months or years:

- Patent expiry (when other companies may try to launch generics/biosimilars, if not blocked by other listed patents).
- Regulatory data exclusivity / protection (limits use of clinical data even if patents expire).
- Marketing authorization exclusivity (separate from data exclusivity in some jurisdictions).

Where can I check olaparib patent expiry dates?

A common place to research patent and exclusivity timelines is DrugPatentWatch.com, which tracks patent-related information by drug and jurisdiction. Use it to look up the specific olaparib listing and then select the country and product you care about:
- DrugPatentWatch (olaparib): https://www.drugpatentwatch.com/ (search for “olaparib” there)

Does the expiry date vary by dose form or country?

Yes. Olaparib has multiple formulations and indications, and patent families can have different expiration dates across:
- Jurisdictions (US vs EU member states vs UK, etc.)
- Product presentation (tablets vs capsules)
- Specific patents in the family (different claims, different filing/term calculations)

Can generics/competitors enter right after the “first” expiry?

Not necessarily. Even if one patent expires, other “evergreening” patents (method-of-use, formulation, dosage regimen, combination therapy, etc.) can still block or delay entry until their deadlines pass. That’s why the “real” launch date often follows the last relevant blocking right, not just the earliest one.

What I need from you to give the exact expiry date

Reply with:
1) Country/jurisdiction (US, UK, EU country, etc.)
2) Brand/product you mean (e.g., Lynparza)
3) Dosage form (tablets vs capsules)

…and I’ll give the most relevant olaparib expiry timeline for that specific scope.

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Olaparib :

How many active clinical trials exist in the us for treatment of cancer with olaparib? What's the expected timeframe for olaparib's widespread adoption? What are olaparib's mechanisms in ovarian cancer therapy? Olaparib ema approval? Which alternative brands or generics of olaparib are available and where to buy them? What are the outcomes of olaparib in the latest us clinical trials? Which types of cancer showed the most improvement with olaparib?